Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer.


BACKGROUND Although several agents have been introduced for the treatment of relapsed small-cell lung cancer (SCLC), there is still only limited evidence regarding second- and later-line chemotherapies for these patients. PATIENTS AND METHODS Consecutive patients with relapsed SCLC treated at the National Cancer Center Hospital between 2000 and 2014 were… (More)
DOI: 10.1016/j.cllc.2016.09.005


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics